Industry News
Feature: Dosing the poison
Associate Professor Martina Stenzel is developing polymer nanoparticles that can help target the effects of chemotherapy drugs on tumours while sparing healthy cells. [ + ]
PR: Nominations now open for State’s science awards
The State’s most prestigious science awards are set to be bigger and better in 2011 with more prize money on offer and three new award categories.
[ + ]Award winner ‘can count fish from space’
A young research scientist who has studied fish from outer space in order to help predict the future of our coral reefs and their fish stocks is this year’s winner of a prestigious science prize.
[ + ]Genetic link between schizophrenia and bi-polar discovered
Two landmark genetic studies have found 11 regions that are associated with both diseases, suggesting some common underlying causes. [ + ]
Achilles heel found in hepatitis C virus
A vaccine and treatment for hepatitis C virus (HCV) are closer with the discovery by Australian researchers of two fatal chinks in the virus’s armour. [ + ]
Prana trial gains interest from Huntington’s disease community
International Huntington's disease patients groups have expressed strong interest in upcoming phase II trials of Prana’s treatment. [ + ]
Nominations now open for 2011 NSW Science and Engineering Awards
NSW prestigious science awards are set to be bigger and better in 2011 with three new award categories.
[ + ]First gravity wave detector step closer to development
Physicists have made a breakthrough in the development of the world’s first gravity wave detector.
[ + ]New immune cell raises prospect of asthma treatment
The suite of immune cells in the human body has increased by one, lending insight into immune responses such as asthma, and raising the possibility of a new treatment for chronic allergies. [ + ]
New chemicals causing concern at CleanUp 2011 Conference
Leading scientists will discuss concerns about the impact on human health and the environment from emerging conaminants at the CleanUp 2011 Conference in Adelaide.
[ + ]HealthLinx makes a push into Chinese market
HealthLinx has partnered with Chinese CRO with a vision to launching ovarian cancer treatment, OvPlex, into Chinese market. [ + ]
Alchemia kicks off phase II lung cancer trial
A phase II trial of anti-cancer drug, HA-Irinotecan, for the treatment of small cell lung cancer, has commenced in Melbourne. [ + ]
The Australian Innovation Challenge Awards
The Australian Innovation Challenge Awards aim to find Australia’s next big inventions in fields ranging from clean energy technology to agriculture to astronomy. Online entries close at midnight (AEST) on Wednesday 28 September.
[ + ]
